Brief: Medicure Acquires License To Sell Cardiovascular Drug In The U.S.

Medicure

14/12/2017 15:17

Dec 14 (Reuters) - Medicure Inc  MPH.V : 
    * MEDICURE ACQUIRES EXCLUSIVE LICENSE TO SELL AND MARKET 
BRANDED 
CARDIOVASCULAR DRUG IN THE U.S. 
    * MEDICURE INC - LICENSING AGREEMENT IS FOR A TERM OF SEVEN 
YEARS 
WITH EXTENSIONS TO TERM AVAILABLE 
    * MEDICURE - THROUGH ITS SUBSIDIARY CO HAS ACQUIRED LICENSE 
TO 
SELL AND MARKET A BRANDED CARDIOVASCULAR DRUG  IN UNITED STATES 
AND ITS TERRITORIES 
    * MEDICURE - CO INTENDS TO LAUNCH THE PRODUCT WITH A TARGET 
COMMERCIAL LAUNCH DATE IN H1 OF 2018 
 
Source text for Eikon:  urn:newsml:reuters.com:*:nCNWNgs88a 
Further company coverage:  MPH.V  
 
 ((Bangalore.newsroom@thomsonreuters.com;))